Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥967.00 JPY
Change Today -19.00 / -1.93%
Volume 2.8K
4952 On Other Exchanges
As of 2:00 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

sds biotech k k (4952) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/27/15 - ¥1,180
52 Week Low
10/14/14 - ¥814.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SDS BIOTECH K K (4952)

Related News

No related news articles were found.

sds biotech k k (4952) Related Businessweek News

No Related Businessweek News Found

sds biotech k k (4952) Details

SDS Biotech K.K. engages in the production, import, and sale of agricultural chemicals, industrial biocides, public health products, and specialty chemicals in Japan and internationally. It offers fungicides, nematicides, paddy herbicides, non-crop herbicides, and biological products, as well as insecticides and plant growth regulators. The company also provides specialty products, including industrial biocides, wood preservative products, wood decay testing kits, and microcapsuled repellents. The company was formerly known as Showa Diamond Chemical K.K. and changed its name to SDS Biotech K.K. in July 1983. The company was founded in 1968 and is headquartered in Tokyo, Japan. SDS Biotech K.K. is a subsidiary of Idemitsu Kosan Co., Ltd.

533 Employees
Last Reported Date: 03/27/15
Founded in 1968

sds biotech k k (4952) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sds biotech k k (4952) Key Developments

SDS Biotech K.K. Reports Consolidated Earnings Results for the Second Quarter Ended June 30, 2015; Provides Consolidated Earnings Guidance and Dividend Guidance for the Fiscal Year Ending March 2016

SDS Biotech K.K. reported consolidated earnings results for the second quarter ended June 30, 2015. For the quarter, the company reported net sales of ¥7,242 million against ¥6,638 million a year ago. Operating income was ¥402 million against ¥337 million a year ago. Ordinary income was ¥231 million against ¥230 million a year ago. Net income was ¥181 million or ¥23.13 per diluted share against ¥117 million or ¥15.00 per diluted share a year ago. Net income before taxes was ¥228,312,000 against ¥232,027,000 a year ago. The company provided consolidated earnings guidance for the fiscal year ending March 2016. For the year, the company expects to report net sales of ¥20,880 million, operating income of ¥2,170 million, ordinary income of ¥1,800 million and net income of ¥1,100 million or ¥140.46 per share. The company provided dividend guidance for the year ended March 31, 2016. For the year the company expects to pay dividend of ¥15.00 as compared to ¥10.00 last year.

SDS Biotech K.K. to Report Q2, 2015 Results on Aug 04, 2015

SDS Biotech K.K. announced that they will report Q2, 2015 results on Aug 04, 2015

SDS Biotech K.K., Q2 2015 Earnings Call, Aug 11, 2015

SDS Biotech K.K., Q2 2015 Earnings Call, Aug 11, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4952:JP ¥967.00 JPY -19.00

4952 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4952.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4952 Industry Range
Price/Earnings 9.0x
Price/Sales 0.5x
Price/Book 1.3x
Price/Cash Flow 7.3x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SDS BIOTECH K K, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at